BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 11.22%57.24M | 13.99%293.19M | 46.76%99.28M | -10.96%63.75M | 82.07%78.69M | -31.14%51.47M | 8.04%257.2M | -16.16%67.65M | 70.51%71.6M | -33.23%43.22M |
Net income from continuing operations | 20.17%45.14M | -8.02%168.9M | 8.84%46.39M | -1.53%45.15M | 0.52%39.8M | -32.39%37.56M | -6.02%183.62M | -21.62%42.62M | -6.55%45.85M | -17.46%39.59M |
Operating gains losses | -143.87%-1.59M | -110.27%-1.31M | -319.37%-2.24M | -181.25%-1.68M | -124.37%-1.02M | -33.73%3.63M | 254.51%12.74M | -55.06%1.02M | 45.15%2.06M | 139.89%4.18M |
Depreciation and amortization | -10.05%4.76M | -4.29%20.7M | -6.77%5.05M | -4.39%5.12M | -3.73%5.24M | -2.25%5.29M | -2.62%21.63M | -2.47%5.42M | -2.71%5.36M | -2.12%5.44M |
Deferred tax | 13.42%7.18M | 526.27%7.06M | -205.26%-881K | 899.77%3.45M | 86.09%-1.84M | -43.30%6.33M | -110.43%-1.66M | 127.31%837K | -128.08%-431K | -247.88%-13.23M |
Other non cashItems | 98.53%29.92M | 701.94%100.96M | 673.29%50.02M | -83.16%1.48M | 453.32%34.39M | 112.81%15.07M | 1,652.40%12.59M | -23.27%6.47M | 149.61%8.77M | -84.85%-9.73M |
Change in working capital | -64.83%-33.22M | -630.19%-21.72M | -172.15%-4.7M | 22.19%6M | -160.69%-2.87M | -67.37%-20.16M | 185.64%4.1M | 51.95%6.51M | 187.83%4.91M | -57.79%4.72M |
-Change in other current assets | 397.97%8.82M | -293.49%-35.29M | -267.41%-21.15M | 774.47%9.04M | 20.73%-24.95M | -79.96%1.77M | 77.02%-8.97M | -23.91%12.63M | 103.16%1.03M | -147.60%-31.47M |
-Change in other current liabilities | -91.74%-42.04M | 3.83%13.57M | 368.71%16.45M | -178.60%-3.05M | -38.98%22.09M | -5.01%-21.93M | -61.85%13.07M | 50.29%-6.12M | -85.70%3.87M | 51.46%36.19M |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | 11.22%57.24M | 13.99%293.19M | 46.76%99.28M | -10.96%63.75M | 82.07%78.69M | -31.14%51.47M | 8.04%257.2M | -16.16%67.65M | 70.51%71.6M | -33.23%43.22M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -199.34%-61.79M | -293.39%-371.17M | 17.57%-66.55M | -272.01%-95.3M | -2,477.62%-271.53M | -79.86%62.21M | 113.29%191.93M | -2.18%-80.73M | 93.55%-25.62M | 98.47%-10.53M |
Net investment purchase and sale | -65.20%43.07M | -43.44%306.69M | -14.03%75.44M | -59.03%47.87M | -62.79%59.61M | -30.26%123.76M | 356.78%542.23M | -60.82%87.76M | 551.35%116.85M | 174.56%160.18M |
Net proceeds payment for loan | -53.55%-110.81M | -6.47%-670.65M | 16.37%-135.45M | -4.43%-148.38M | -0.30%-314.66M | -493.35%-72.16M | 37.63%-629.92M | 45.76%-161.96M | 61.20%-142.08M | -2.50%-313.72M |
Net PPE purchase and sale | 25.42%-1.66M | 6.17%-13.75M | -25.42%-3.79M | 45.66%-3.33M | -24.96%-4.4M | -12.25%-2.23M | 0.50%-14.65M | -21.98%-3.03M | -26.73%-6.12M | 14.29%-3.52M |
Net business purchase and sale | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net other investing changes | -40.77%7.6M | 214.08%6.54M | 21.46%-2.75M | 48.68%8.53M | -248.13%-12.07M | 385.30%12.83M | 85.85%-5.73M | -80.80%-3.5M | 143,350.00%5.74M | -225.93%-3.47M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -199.34%-61.79M | -293.39%-371.17M | 17.57%-66.55M | -272.01%-95.3M | -2,477.62%-271.53M | -79.86%62.21M | 113.29%191.93M | -2.18%-80.73M | 93.55%-25.62M | 98.47%-10.53M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 65.15%-55.36M | 174.33%325.38M | -161.03%-9.67M | 447.74%262.89M | 3,989.57%231.02M | 58.59%-158.86M | 36.07%-437.73M | 102.73%15.84M | -1,362.91%-75.6M | 102.94%5.65M |
Increase decrease in deposit | -38.99%78.87M | 182.11%484.9M | 83.63%-23.75M | 507.83%458.89M | -44.18%-79.51M | 127.75%129.27M | -11.71%-590.56M | 76.38%-145.06M | 247.88%75.5M | 58.54%-55.15M |
Net issuance payments of debt | 56.87%-116.67M | -140.62%-90.62M | -82.68%30.73M | -33.32%-179.42M | 318.86%328.62M | -365.84%-270.54M | 376.46%223.08M | 263.65%177.44M | -18,310.40%-134.58M | 344.87%78.46M |
Net commonstock issuance | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Cash dividends paid | -0.55%-16.78M | 0.05%-66.73M | -0.38%-16.56M | -0.33%-16.55M | 0.59%-16.93M | 0.28%-16.69M | -9.31%-66.77M | -9.58%-16.5M | -9.59%-16.5M | -8.00%-17.03M |
Net other financing activities | 14.88%-772K | 37.51%-2.17M | -102.56%-79K | -42.11%-27K | -83.68%-1.16M | 67.46%-907K | -4.32%-3.48M | 35.00%-39K | -128.36%-19K | -608.99%-631K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 65.15%-55.36M | 174.33%325.38M | -161.03%-9.67M | 447.74%262.89M | 3,989.57%231.02M | 58.59%-158.86M | 36.07%-437.73M | 102.73%15.84M | -1,362.91%-75.6M | 102.94%5.65M |
Net cash flow | ||||||||||
Beginning cash position | 97.22%501.86M | 4.69%254.46M | 90.22%478.8M | -12.04%247.46M | -13.88%209.28M | 4.69%254.46M | -88.61%243.06M | -69.38%251.71M | -75.97%281.33M | -87.78%242.99M |
Current changes in cash | -32.59%-59.91M | 2,069.74%247.39M | 736.22%23.06M | 881.04%231.34M | -0.39%38.18M | -64,454.29%-45.19M | 100.60%11.4M | 100.48%2.76M | 91.51%-29.62M | 104.69%38.33M |
End cash position | 111.18%441.95M | 97.22%501.86M | 97.22%501.86M | 90.22%478.8M | -12.04%247.46M | -13.88%209.28M | 4.69%254.46M | 4.69%254.46M | -69.38%251.71M | -75.97%281.33M |
Free cash flow | 12.87%55.58M | 15.21%279.44M | 47.76%95.49M | -7.71%60.43M | 87.14%74.29M | -32.32%49.24M | 8.61%242.55M | -17.37%64.62M | 76.20%65.48M | -34.51%39.7M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |